4 options
Small Molecules in Oncology / edited by Uwe M. Martens.
LIBRA RC261 .R35 v.1 (1965)-v.5 (1966), v.7 (1966)-v.98 (1985), v.100 (1986)-v.121 (1991), v.123 (1991)-v.126 (1993), v.128 (1993)-v.158 (2000); v.13:2nd ed. (1976) 1969
Available from offsite location
Holman Biotech Commons - Periodicals Per. v.159 (2002)-184,186,188-189,191-192,194-196
Mixed Availability
Levy Dental Medicine Library - Stacks RC261 .R35 149
Mixed Availability
- Format:
- Book
- Series:
- Recent results in cancer research 0080-0015 ; 211.
- Recent Results in Cancer Research, 0080-0015 ; 211
- Language:
- English
- Subjects (All):
- Medicine.
- Cancer--Research.
- Cancer.
- Oncology.
- Medicine & Public Health.
- Cancer Research.
- Local Subjects:
- Medicine & Public Health.
- Oncology.
- Cancer Research.
- Physical Description:
- 1 online resource (VIII, 276 pages) : 34 illustrations, 19 illustrations in color.
- Edition:
- Third edition 2018.
- Contained In:
- Springer eBooks
- Place of Publication:
- Cham : Springer International Publishing : Imprint: Springer, 2018.
- System Details:
- text file PDF
- Summary:
- This book, written by respected experts, discusses in detail the latest developments in targeted oncology therapy using small molecules. It covers a wide range of small molecules, including tyrosine kinase inhibitors, mTOR, MEK, PARP, and multikinase inhibitors, as well as cell cycle and NTRK interacting agents. For each molecule, aspects such as the chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed. Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of personalized cancer therapy is now growing rapidly, and the advances being made will mean significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. This book is the third edition of Small Molecules in Oncology, but has now been divided into two volumes, with the other volume focusing specifically on small molecules in hematology. .
- Contents:
- Erlotinib
- Lapatinib
- Sorafenib
- Regorafenib
- Crizotinib
- Cabozantinib
- Vemurafenib
- Trametinib
- Everolimus
- Vismodegib
- Larotrectinib
- Palbociclib
- Taselisib
- Cobimetinib
- Lenvatinib
- Afatinib
- Olaparib
- Gefitinib
- Ceritinib. .
- Other Format:
- Printed edition:
- ISBN:
- 9783319914428
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.